Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

Normally I'd agree - but on 3yr paper

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
10nisman Member Profile
 
Followed By 6
Posts 1,506
Boards Moderated 0
Alias Born 10/26/03
160x600 placeholder
S&P 500 Posts Biggest Weekly Gain Of 2014
U.S. stocks closed with solid gains Friday, leaving the S&P 500 with its largest weekly advance of the year.
Top Equities Stories Of The Day
European Markets Show Signs of Stress--2nd Update
Microsoft Gains Help Lead Tech's Advance
Treasury Bonds Pull Back for Second Straight Day
Will Free Data Become the Next Free Shipping?
Microsoft Braces for Another Nokia Hit--Earnings Preview
Procter & Gamble Looking at Margins, Brands--Earnings Preview
Stifel Financial to Hire Two Former Merrill Lynch Advisers
Pfizer Results Will Play Second Fiddle to Dealmaking Outlook -- Earnings Preview
10nisman   Thursday, 09/23/10 12:08:13 PM
Re: wallstarb post# 104887
Post # of 183180 
Quote:
Normally I'd agree - but on 3yr paper it doesnt have the duration for a longer term investment, and unless MSFT is buying junk bonds with it I really dont see the point for them. Perhaps an acquisition on the horizon - or maybe they are buying some CMOs

The vast majority of MSFT's cash is overseas and thus to get around paying taxes to repatriate it they chose to issue debt at insanely attractive levels. MSFT will likely use the cash to pay its dividend and buy-back shares.

10nis

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist